Trick or Trade- Prohost Biotech - Exclusive Biotech Research

Category: Trick or Trade

There Is A Lot More To Say About the COVID-19 Vaccines

Pfizer and BioNTech Vaccines Were Granted FDA Fast Track Designation Against SARS-CoV-2 (COVID-19) A large Phase 2b/3 safety and efficacy study may begin as early as July 2020 Pfizer ( PFE ) and BioNTech ( BNTX ) announced that two...

July 13, 2020

Could Arbutus Biopharma's Patent Harm Moderna?

Arbutus Biopharma and Moderna's Patent Challenge Arbutus Biopharma ( ABUS ) is a publicly-traded biopharmaceutical company dedicated to discovering and developing a cure for patients suffering from chronic hepatitis B infection. The stock has been in the Aggressive Table of...

July 24, 2020

Edesa Biotech Stock Price Soared. Will It Continue to Rise?

Edesa Biotech Filed an IND for EB05 Edesa Biotech ( EDSA ) , a clinical-stage biopharmaceutical company, has filed an investigational new drug ( IND ) application with the U.S. FDA for the initiation of a Phase 2/3 clinical study...

July 30, 2020

Alterity Therapeutics: Treating Neurodegenerative Diseases?

When a small firm’s stock price soars, and more than doubles, curiosity pushes us to investigate. Alterity Therapeutics Yesterday the stock soared for a firm called Alterity Therapeutics ( ATHE ) closing at $3.43 UP $2.08. We found that...

August 5, 2020

Monopar Therapeutics: A Plan for a Test that Predicts COVID-19 Patients Who Might Likely Develop Severe Respiratory Failure

A Predictive COVID-19 Test? COVID-19 infected people are not all affected to the same degree with regards to the severity of the disease complications. There is no doubt that a test that can predict which patients will be severely affected...

August 13, 2020

An Important Announcement from Sorrento Therapeutics

Sorrento Therapeutics Announcement Sorrento Therapeutics ( SRNE ) announced that it believes it has uncovered fraudulent attempts to manipulate the Company’s stock. In a press release from August 12, 2020 Sorrento informed that, on August 11, 2020 it was reported...

August 13, 2020

An Evaluation of Biotech Firms Part 4

A Comprehensive Essay Part 4 Our fair evaluation approaches of biotechnology and biopharma companies differ depending on the sizes and statuses of the firms. We reiterate our conviction that causing a selloff of development stage biotech stocks at every announcement...

April 13, 2020

The FDA's Complete Response Letters, Creating Investment Opportunities?

Yesterday, under Today’s Highlights , we posted that the U.S. FDA issued a Complete Response Letter ( CRL ) to Gilead Sciences ( GILD ) with regard to the New Drug Application ( NDA ) for filgotinib - the investigational...

August 20, 2020

What's Going on with Gene Therapy?

Recent Gene Therapy News On August 20, 2020 Audentes Therapeutics , which was taken over by Astellas ( ALPMY ) for over $3 billion, announced that a third patient has passed away in a clinical trial evaluating its gene therapy...

August 25, 2020

Agenus: Could It Be a Resurrection? See Also: Prohost Performing Stocks

Agenus Announced Data from Phase 2 Trials of Balstilimab Agenus ( AGEN ) immuno-oncology company announced that data from two Phase 2 trials of balstilimab alone and in combination with zalifrelimab will be orally presented in at the upcoming European Society...

September 2, 2020

Search ProhostBiotech

Recent

AstraZeneca Product Fasenra Approved in the US for Eosinophilic Granulomatosis with Polyangiitis

September 19, 2024

The U.S. FDA Approves Novartis' Kisqali® to Reduce the Risk of Recurrence in People with HR+/HER2- Early Breast Cancer

September 18, 2024

AstraZeneca’s Imfinzi + Imjudo Demonstrated Unprecedented Overall Survival in Advanced Liver Cancer

September 17, 2024

Halozyme Therapeutics Announced FDA Approval of Roche’s Tecentriq Hybreza with ENHANZE

September 13, 2024

Johnson & Johnson Product TREMFYA® Receives U.S. FDA Approval

September 12, 2024